STZ CONSTELLATION BRANDS, INC. Insider Trading

Director Baldwin buys 2,000 STZ shares for $340.9K at $170.44 avg; stock down 8.5% in 90 days, company posted FY loss

Baldwin Christopher J, a director at Constellation Brands, purchased 2,000 shares across two transactions on 2025-07-07 and 2025-07-08 at prices of $171.27 and $169.62, totaling $340,886.10, increasing his holdings by 961.5% from 208 to 2,208 shares. The purchases occurred while the stock traded at a blended average price of $170.44, which is $1.40 above the current price of $169.04 and 34.9% below the 52-week high of $259.82. Context is important: Constellation reported a full-year net loss in its most recent fiscal year despite posting $2,515,000,000.00 in quarterly revenue, and the stock has declined 8.5% over the past 90 days and 1.2% over the past 30 days. This substantial accumulation by a director occurs against a backdrop of negative recent returns and balance-sheet stress, making the motivation for the purchase timing and sizing a relevant data point for investors evaluating management's confidence at current valuations.

Director William T. Giles purchased 1,000 STZ shares at $186.39; holdings increased 216% to 1,463 shares post-transaction.

Director William T. Giles executed an open-market purchase of 1,000 shares at $186.39 on 2025-01-17, tripling his prior holding from 463 shares to 1,463 shares. The transaction occurred during a period of material price weakness: the stock trades at $183.08, down 32.7% from its 52-week high of $272.04 and down 19.6% over the preceding 30 days. The company remains fundamentally sound, with $2.5B in latest-quarter revenue and net income of $615.9M, supported by annual revenue growth of 5.4%. The significant expansion of his personal stake during a sharp drawdown warrants investor attention to the underlying signal—whether this represents conviction in the current valuation, a routine portfolio action, or other factors not disclosed in the filing.

ZMSS Business Holdings LP sold 59,637 shares of STZ at $240.38 on 2024-11-13 for $14.3M; post-trade hold 3.31M shares

ZMSS Business Holdings LP completed a $14.3M open-market sale of 59,637 shares of Constellation Brands (STZ) at $240.38, reducing its position by 1.8% to 3.31M shares. The insider's prior sale of STZ on 2023-05-10 showed a 90-day return of +21.2%, indicating the prior sell occurred before a significant stock run—not well-timed by the standard that sales are well-timed only when the stock declines post-sale. With STZ currently at $237.51, down 12.7% from its 52-week high and off 2.5% in the past 30 days, the transaction occurred near what has proven to be a local peak, though the subsequent market action (current price vs. transaction price) remains nascent. The company reported a $-1.2B net loss against $2.9B quarterly revenue in the latest period, a fundamental backdrop that may inform larger questions about the business trajectory independent of this single insider trade.

Director Richard Sands sold 59,637 shares of STZ at $240.38 on 2024-11-13, retaining 20.43M shares.

Richard Sands, a director at Constellation Brands, sold 59,637 shares for a total of $14,335,542.06 at $240.38 per share, representing a 0.3% reduction in his 20.43M-share position. The sale occurred when the stock was trading 12.7% below its 52-week high of $272.04 and has since declined another 2.5% over 30 days and 3.3% over 90 days. Against this backdrop, the company reported a net loss of $1,199,000,000.00 in the latest quarter despite positive revenue growth of 5.4% year-over-year and $2,918,900,000.00 in latest quarterly revenue. The modest size of this transaction—a fractional reduction of an already substantial holdings position—combined with the company's loss position and recent downward momentum suggests limited direct signal about insider conviction or outlook.

EVP & Pres. Beer Sabia James A. Jr. sold 36,086 shares of STZ at $242.99 on 2024-11-14; holds 16,042 post-sale amid net loss quarter.

Sabia James A. Jr., EVP and President of Beer for Constellation Brands, sold 36,086 shares (36.1K shares) at $242.99 on 2024-11-14 for $8,768,540.75 ($8.8M), reducing his stake by 69.2% from 52,128 shares to 16,042 shares post-transaction. The sale is noteworthy given timing within a broader context: the company reported a net loss of $-1,199,000,000.00 ($-1.2B) in its latest quarter, while STZ has declined -12.7% from its 52-week high of $272.04 and -2.5% over the past 30 days. His cross-ticker track record shows a 100.00% well-timed rate on prior sells (meaning prior sales preceded stock declines), and his single prior STZ trade on 2024-04-12 posted a -1.6% 90-day return, consistent with ahead-of-decline execution. However, this transaction contains a derivative-conversion flag: the Form 4 Table II (derivative securities) is not yet populated in the database, meaning the 16,042 shares shown post-transaction may not represent his total economic position and should not be read as a position exit. Investors should await Table II data to assess the insider's full derivative holdings.

WildStar Partners LLC (10% owner) sold 59,637 shares of STZ at $240.38 on 2024-11-13 for $14.3M; still holds 3.31M shares post-sale.

WildStar Partners, a 10% stakeholder, sold 59,637 shares at $240.38, reducing holdings by 1.8% while retaining 3.31M shares. The sale occurred near but below the 52-week high of $272.04, with the stock now trading at $237.51 (-12.7% from peak). Critically, the company is operationally challenged: the latest quarter shows net income of -$1,199,000,000, a significant loss despite $2.9B in quarterly revenue and 5.4% annual growth. WildStar's prior trades at STZ show 0 of 5 prior sells were well-timed at the 90-day mark (all five prior sells recorded positive 90-day returns, meaning the stock rose after each sale), suggesting this insider has historically exited before gains materialized at this ticker. The persistent unprofitability against modest revenue growth warrants attention to whether this disposition signals recognition of margin pressures or structural headwinds.

Director Robert Sands sold 59,637 shares of STZ at $240.38 for $14.3M on 2024-11-13

Director Robert Sands sold 59,637 shares at $240.38, representing a -0.3% reduction from his 20.49M-share position. The sale occurred at a price 1.2% above the current market price of $237.51 and 11.7% below the 52-week high of $272.04. His prior three trades at STZ (all sales on 2024-10-16) showed modest negative returns over 30 days (-1.9%, -2.1%, -2.4%), and his broader cross-ticker track record shows an average 30-day return of -2.1% after sells. The company reported a $-1.2B net loss in its latest quarter despite 5.4% annual revenue growth, suggesting operational headwinds despite top-line expansion. The timing of this sale relative to STZ's 12.7% decline from its 52-week high and recent stock momentum warrants monitoring given his substantial remaining stake of 20.43M shares.

Stern sold 59,637 STZ shares at $240.38 on 2024-11-13 for $14.3M; stock now -12.7% from 52-week high.

Zachary M Stern sold 59,637 shares of Constellation Brands (STZ) at $240.38 in November 2024, reducing his holdings from 3,365,715 to 3,306,078 shares—a 1.8% reduction in his position. The stock is now trading at $237.51, down 2.5% in 30 days and 3.3% in 90 days, placing it 12.7% below its 52-week high of $272.04. Stern's four prior sales at STZ all occurred on the same date (2023-05-10) and each showed 30-day returns of +8.1% and 90-day returns of +21.2%, indicating his prior sells at this ticker were not well-timed—the stock rose after each sale. In his broader cross-ticker track record, his average 90-day return after sells was +21.2% with a 0% well-timed rate, suggesting a consistent pattern of selling before subsequent gains. The company reported a net loss of $1.2B on revenue of $2.9B in the latest quarter, alongside annual revenue growth of 5.4%, providing context of recent operational challenges.

STZ President & CEO Newlands sold 25,000 shares ($6.1M) on 2024-11-14; holdings reduced to 7.3K; stock down 12.7% from 52-week high.

William A Newlands sold 25,000 shares of Constellation Brands at $243.58, reducing his holdings by 77.5% to 7,274 shares post-transaction. Across his same-ticker history at STZ, all four prior measurable sells have been well-timed at the 90-day mark, with returns ranging from -3.0% to -12.5%, indicating a consistent pattern of selling before declines. The current price of $237.51 sits 12.7% below the 52-week high and 2.5% below the 30-day average, placing this sale in a period of stock weakness. However, the company faces material headwinds: net income stands at -$1.2B against revenue of $2.9B, even as annual revenue growth remains positive at 5.4%, suggesting profitability challenges despite top-line expansion. The large reduction in personal holdings warrants attention to whether this reflects broader business concerns or is driven by scheduled grant diversification.

Newlands sells 7,426 STZ shares at $237.24; cuts holdings by -50.5%, stock down -14.6% from 52-week high

Newlands William A (President & CEO) sold 7,426 shares (7.4K shares) of STZ on 2024-10-29 at $237.24, reducing his position by -50.5% from 14,700 to 7,274 shares. The sale occurred near a recent peak: STZ is now trading at $232.34, -14.6% from its 52-week high of $272.04 and down -9.8% over 30 days. His prior five trades at STZ were all well-timed sells, with 90-day declines of -8.2%, -8.5%, -5.7%, -12.5%, and -12.9%, establishing a 100% accuracy rate in timing exits at this ticker. Notably, the company reported a net loss of $-1,199,000,000.00 in the latest quarter despite 5.4% annual revenue growth, creating a disconnect between growth and profitability that may have motivated the substantial reduction in the CEO's direct holdings.